变化型态的消脂症管理: 2019年ESC/EAS指南和2025年重点更新之间的比较
Marco Zuin1,2,3, Claudio Bilato4
1Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Internal and emergency medicine
|December 16, 2025
概括
2025年欧洲心脏病学会 (ESC) 和欧洲动脉样硬化学会 (EAS) 关于失脂症管理的指导方针现在强调个性化,早期干预. 新的风险评分和组合疗法旨在改善心血管疾病预防和患者的治疗结果.
科学领域:
- 心脏病学和动脉样硬化研究
背景情况:
- 欧洲心脏病学会 (ESC) 和欧洲动脉样硬化学会 (EAS) 之前曾在治疗失脂症方面采用针对性方法.
- 像SCORE这样的风险分层模型在预测心血管事件和评估不同人群方面存在局限性.
研究的目的:
- 概述了2025年ESC/EAS指南中的关键更新,用于治疗失脂症.
- 突出转向更早,个性化治疗策略和改善心血管风险评估的转变.
主要方法:
- 审查和综合最近的临床证据和指导方针建议.
- 从SCORE过渡到SCORE2和SCORE2-OP,以提高心血管风险分层.
- 包括新的生物标志物,并考虑代表性不足的患者群体.
主要成果:
- 2025年的指导方针倡导更早,更密集,个性化的失脂症管理.
- 更新的风险评分 (SCORE2,SCORE2-OP) 提高了准确性,特别是在老年人中.
- 与非他类药物的联合疗法可以实现较低的LDL目标 (例如,<40 mg/dL).
- 重点是生物标志物如脂蛋白和甘油三,并包括艾滋病毒阳性和瘤患者.
- 重申未经证实的补充剂和营养保健品的有限疗效.
结论:
- 更新的指南巩固了"更早,更密集,更个性化"心血管预防的范式.
- 基于证据的这些策略的临床实施对于优化患者的预后和生活质量至关重要.
相关概念视频
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K
Angina IV: Management
215
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
215
Lipid-derived Compounds in the Human Body
6.2K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
6.2K
Coronary Artery Disease IV: Preventive Measures
572
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
572


